ConductScience.org, home

Paper23344239

Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals.

Seth PP and 5 others. Mol Ther Nucleic Acids, 2012. Cited by 32 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals. Papers, record 23344239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23344239

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals.
PubMed
Journal
Mol Ther Nucleic Acids
PubMed
Year
2012
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2022-08-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Seth PPPunit P
2Jazayeri AAli
3Yu JJeff
4Allerson CRCharles R
5Bhat BBalkrishen
6Swayze EEEric E

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118710289Nucleic acid structural engineering using pyrene-functionalized 2'-amino-alpha-L-LNA monomers and abasic sites.J Org Chem2008https://conductscience.org/library/papers/18710289PubMed
221075634Replacing the 2'-oxygen with an exocyclic methylene group reverses the stabilization effects of α-L-LNA.Bioorg Med Chem Lett2011https://conductscience.org/library/papers/21075634PubMed
3153575903'-C-Branched LNA-type nucleosides locked in an N-type furanose ring conformation: synthesis, incorporation into oligodeoxynucleotides, and hybridization studies.J Org Chem2004https://conductscience.org/library/papers/15357590PubMed
415861430On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.Chembiochem2005https://conductscience.org/library/papers/15861430PubMed
520227758
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.
Lancet2010https://conductscience.org/library/papers/20227758PubMed
6175519172'-N-(pyren-1-yl)acetyl-2'-amino-alpha-L-LNA: synthesis and detection of single nucleotide mismatches in DNA and RNA targets.Chembiochem2007https://conductscience.org/library/papers/17551917PubMed
710985717Structural studies of LNA:RNA duplexes by NMR: conformations and implications for RNase H activity.Chemistry2000https://conductscience.org/library/papers/10985717PubMed
820055705RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform.Annu Rev Pharmacol Toxicol2010https://conductscience.org/library/papers/20055705PubMed
922530946
Intramolecular free-radical cyclization reactions on pentose sugars for the synthesis of carba-LNA and carba-ENA and the application of their modified oligonucleotides as potential RNA targeted therapeutics.
Chem Rev2012https://conductscience.org/library/papers/22530946PubMed
1022467214TricycloDNA-modified oligo-2'-deoxyribonucleotides reduce scavenger receptor B1 mRNA in hepatic and extra-hepatic tissues--a comparative study of oligonucleotide length, design and chemistry.Nucleic Acids Res2012https://conductscience.org/library/papers/22467214PubMed
1118368051LNA-mediated microRNA silencing in non-human primates.Nature2008https://conductscience.org/library/papers/18368051PubMed
1220886816An exocyclic methylene group acts as a bioisostere of the 2'-oxygen atom in LNA.J Am Chem Soc2010https://conductscience.org/library/papers/20886816PubMed
1321709231Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs).Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21709231PubMed
1420108935
Antisense oligonucleotides containing conformationally constrained 2',4'-(N-methoxy)aminomethylene and 2',4'-aminooxymethylene and 2'-O,4'-C-aminomethylene bridged nucleoside analogues show improved potency in animal models.
J Med Chem2010https://conductscience.org/library/papers/20108935PubMed
1520615897Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates.Nucleic Acids Res2010https://conductscience.org/library/papers/20615897PubMed
1621058707Configuration of the 5'-methyl group modulates the biophysical and biological properties of locked nucleic acid (LNA) oligonucleotides.J Med Chem2010https://conductscience.org/library/papers/21058707PubMed
1721778053Synthesis and biophysical evaluation of 3'-Me-α-L-LNA - Substitution in the minor groove of α-L-LNA duplexes.Bioorg Med Chem Lett2011https://conductscience.org/library/papers/21778053PubMed
1822614180Structure and nuclease resistance of 2',4'-constrained 2'-O-methoxyethyl (cMOE) and 2'-O-ethyl (cEt) modified DNAs.Chem Commun (Camb)2012https://conductscience.org/library/papers/22614180PubMed
1911878970alpha-L-ribo-configured locked nucleic acid (alpha-L-LNA): synthesis and properties.J Am Chem Soc2002https://conductscience.org/library/papers/11878970PubMed
2010640282Chemically modified oligonucleotides exhibit decreased immune stimulation in mice.J Pharmacol Exp Ther2000https://conductscience.org/library/papers/10640282PubMed

See all 37 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
42814296Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers.Methods Mol Biol2026https://conductscience.org/library/papers/42814296PubMed
38654375Regulation of human microglial gene expression and function via RNAase-H active antisense oligonucleotides in vivo in Alzheimer's disease.Mol Neurodegener2024https://conductscience.org/library/papers/38654375PubMed
38042877Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry.Nat Commun2023https://conductscience.org/library/papers/38042877PubMed
33876937Nuclease Hydrolysis Does Not Drive the Rapid Signaling Decay of DNA Aptamer-Based Electrochemical Sensors in Biological Fluids.Langmuir2021https://conductscience.org/library/papers/33876937PubMed
33544849Site-specific incorporation of 5'-methyl DNA enhances the therapeutic profile of gapmer ASOs.Nucleic Acids Res2021https://conductscience.org/library/papers/33544849PubMed
30913332Mirror-Image Oligonucleotides: History and Emerging Applications.Chemistry2019https://conductscience.org/library/papers/30913332PubMed
29499955A Sensitive In Vitro Approach to Assess the Hybridization-Dependent Toxic Potential of High Affinity Gapmer Oligonucleotides.Mol Ther Nucleic Acids2018https://conductscience.org/library/papers/29499955PubMed
29246296Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes.Mol Ther Nucleic Acids2017https://conductscience.org/library/papers/29246296PubMed
29107969Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia.PLoS One2017https://conductscience.org/library/papers/29107969PubMed
29062429Enzymatic separation of epimeric 4-C-hydroxymethylated furanosugars: Synthesis of bicyclic nucleosides.Beilstein J Org Chem2017https://conductscience.org/library/papers/29062429PubMed
29052679Oligonucleotide modifications enhance probe stability for single cell transcriptome in vivo analysis (TIVA).Org Biomol Chem2017https://conductscience.org/library/papers/29052679PubMed
27466159Development of Antisense Drugs for Dyslipidemia.J Atheroscler Thromb2016https://conductscience.org/library/papers/27466159PubMed
27461380Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.Sci Rep2016https://conductscience.org/library/papers/27461380PubMed
27061947Injection site reactions after subcutaneous oligonucleotide therapy.Br J Clin Pharmacol2016https://conductscience.org/library/papers/27061947PubMed
26890856A novel dual lock method for down-regulation of genes, in which a target mRNA is captured at 2 independent positions by linked locked nucleic acid antisense oligonucleotides.RNA Biol2016https://conductscience.org/library/papers/26890856PubMed
26553810Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts.Nucleic Acids Res2016https://conductscience.org/library/papers/26553810PubMed
26258894DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing.Nat Commun2015https://conductscience.org/library/papers/26258894PubMed
25334092Targeting of repeated sequences unique to a gene results in significant increases in antisense oligonucleotide potency.PLoS One2014https://conductscience.org/library/papers/25334092PubMed
25072142Defining the factors that contribute to on-target specificity of antisense oligonucleotides.PLoS One2014https://conductscience.org/library/papers/25072142PubMed
24797769C5-alkynyl-functionalized α-L-LNA: synthesis, thermal denaturation experiments and enzymatic stability.J Org Chem2014https://conductscience.org/library/papers/24797769PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23344239

GET https://conductscience.org/api/papers/v1/23344239/references?page=2